UPDATE -- Encysive Pharmaceuticals Reports Fourth Quarter and Year End 2007 Financial Results
21. März 2008 07:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, March 21, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) previously reported the filing of its annual report on Form 10-K for the year ended December 31, 2007. This...
Encysive Pharmaceuticals Reports Fourth Quarter and Year End 2007 Financial Results
17. März 2008 17:19 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, March 17, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the filing of its annual report on Form 10-K for the year ended December 31, 2007. This filing...
Encysive Pharmaceuticals Announces Date Change for Reporting 2007 Year-End Financials
22. Februar 2008 07:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Feb. 22, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the Company has changed the date for reporting its fourth quarter and year end 2007...
Encysive Pharmaceuticals Launches THELIN (Sitaxentan Sodium) in Sweden
31. Januar 2008 02:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 31, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in Sweden....
Encysive Pharmaceuticals Launches THELIN (sitaxentan sodium) in Belgium and Luxembourg
14. Januar 2008 02:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 14, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in Belgium and...
Encysive Pharmaceuticals Announces Patent Infringement Lawsuit Against Barr Laboratories
28. Dezember 2007 16:01 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 28, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that Mitsubishi Chemical Corporation, the patent holder for Argatroban injections, Mitsubishi...
Encysive Pharmaceuticals Receives Delisting Warning Letter From NASDAQ
19. Dezember 2007 16:15 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 19, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) announced that today it received a delisting warning letter from the Nasdaq Stock Market, notifying it that the...
Encysive Pharmaceuticals Provides THELIN Sales Guidance for 2007 and 2008
14. Dezember 2007 07:15 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 14, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced guidance for sales of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets for 2007 and 2008....
Encysive Pharmaceuticals Launches Thelin (sitaxentan sodium) in Italy
26. November 2007 02:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 26, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in Italy for...
Encysive Pharmaceuticals Announces Presentation of Sitaxsentan Data in Eisenmenger Syndrome At AHA Meeting
05. November 2007 17:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Nov. 5, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals, Inc. (Nasdaq:ENCY) today announced that open label observational data from Columbia University suggests that sitaxsentan (THELIN), a...